Quote | Vickers Vantage Corp. I (NASDAQ:VCKA)
Last: | $9.01 |
---|---|
Change Percent: | 9.7% |
Open: | $9.03 |
Close: | $9.01 |
High: | $10.52 |
Low: | $8.5 |
Volume: | 115,491 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Vickers Vantage Corp. I (NASDAQ:VCKA)
SEC declared Effectiveness of Vickers’s registration statement on Form S-4 Extraordinary General Meeting of Vickers Vantage Corp. I shareholders to approve the proposed Business Combination is scheduled to be held on November 9, 2022, at 10:00 a.m., Eastern Time Post-closin...
SP-103 receives Fast Track Designation, which makes it eligible for some or all of the following: More frequent meetings or written communication with the FDA to discuss the SP-103 development plan and ensure collection of appropriate data needed to support drug approval. ...
Message Board Posts | Vickers Vantage Corp. I (NASDAQ:VCKA)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Vickers Vantage Corp. I Company Name:
VCKA Stock Symbol:
NASDAQ Market:
SEC declared Effectiveness of Vickers’s registration statement on Form S-4 Extraordinary General Meeting of Vickers Vantage Corp. I shareholders to approve the proposed Business Combination is scheduled to be held on November 9, 2022, at 10:00 a.m., Eastern Time Post-closin...
SP-103 receives Fast Track Designation, which makes it eligible for some or all of the following: More frequent meetings or written communication with the FDA to discuss the SP-103 development plan and ensure collection of appropriate data needed to support drug approval. ...
PALO ALTO, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain, today announced the signing of a Product Dist...